颅内动脉粥样硬化疾病继发的烟雾病现象：通过3T磁共振成像诊断
Moyamoya phenomenon secondary to intracranial atherosclerotic disease: diagnosis by 3T magnetic resonance imaging.
作者信息
Ashley William W, Zipfel Gregory J, Moran Christopher J, Zheng Jie, Derdeyn Colin P
机构信息
Washington University School of Medicine, Department of Neurological Surgery, St Louis, MO 63110, USA.
出版信息
J Neuroimaging. 2009 Oct;19(4):381-4. doi: 10.1111/j.1552-6569.2008.00272.x.
Abstract
Moyamoya phenomenon occurs in response to an occlusive vasculopathy affecting the distal internal carotid artery and its proximal branches. The nature of the occlusive vasculopathy is unknown in most patients. We present a patient in whom 3T magnetic resonance imaging was used to examine the arterial wall at the site of occlusion in a patient with unilateral moyamoya phenomenon. Signal characteristics were consistent with atherosclerotic disease. 3T magnetic resonance imaging may be useful for distinguishing the underlying etiology of moyamoya phenomenon in some patients.
摘要
烟雾病样现象是由影响颈内动脉远端及其近端分支的闭塞性血管病变引起的。在大多数患者中，闭塞性血管病变的性质尚不清楚。我们报告了一名单侧烟雾病样现象患者，使用3T磁共振成像检查了闭塞部位的动脉壁。信号特征与动脉粥样硬化疾病一致。3T磁共振成像可能有助于区分某些患者烟雾病样现象的潜在病因。
相似文献
1
Moyamoya phenomenon secondary to intracranial atherosclerotic disease: diagnosis by 3T magnetic resonance imaging.
J Neuroimaging. 2009 Oct;19(4):381-4. doi: 10.1111/j.1552-6569.2008.00272.x.
2
Stenosis of the proximal external carotid artery in an adult with moyamoya disease: moyamoya or atherosclerotic change?
Neurol Med Chir (Tokyo). 2007 Aug;47(8):356-9. doi: 10.2176/nmc.47.356.
3
High-resolution magnetic resonance wall imaging findings of Moyamoya disease.
Stroke. 2014 Aug;45(8):2457-60. doi: 10.1161/STROKEAHA.114.004761. Epub 2014 Jun 19.
4
Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings.
J Neurosurg. 2013 May;118(5):1030-4. doi: 10.3171/2013.1.JNS12565. Epub 2013 Feb 8.
5
Intracranial vasculopathy in a patient with systemic sclerosis: atherosclerotic or moyamoya-like disease?
Korean J Intern Med. 2012 Jun;27(2):239-42. doi: 10.3904/kjim.2012.27.2.239. Epub 2012 May 31.
6
Mechanism of moyamoya vessels secondary to intracranial atherosclerotic disease: angiographic findings in patients with middle cerebral artery occlusion.
J Stroke Cerebrovasc Dis. 2012 Jul;21(5):373-8. doi: 10.1016/j.jstrokecerebrovasdis.2010.10.001. Epub 2010 Nov 26.
7
Response to letter regarding article, "high-resolution magnetic resonance wall imaging findings of Moyamoya disease".
Stroke. 2014 Dec;45(12):e300. doi: 10.1161/STROKEAHA.114.007219. Epub 2014 Oct 14.
8
Letter by Shang et al regarding article, "high-resolution magnetic resonance wall imaging findings of Moyamoya disease".
Stroke. 2014 Dec;45(12):e299. doi: 10.1161/STROKEAHA.114.007151. Epub 2014 Oct 14.
9
Routine clinical evaluation of cerebrovascular reserve capacity using carbogen in patients with intracranial stenosis.
Stroke. 2014 Aug;45(8):2335-41. doi: 10.1161/STROKEAHA.114.005975. Epub 2014 Jun 17.
10
High-resolution MR technique can distinguish moyamoya disease from atherosclerotic occlusion.
Neurology. 2013 Feb 19;80(8):775-6. doi: 10.1212/WNL.0b013e3182825162.
引用本文的文献
1
Bowel Ischemia as a Rare Manifestation of Extracranial Moyamoya Disease: A Case Report.
Am J Case Rep. 2025 Jul 6;26:e949530. doi: 10.12659/AJCR.949530.
2
Recent Advances in Stroke Genetics-Unraveling the Complexity of Cerebral Infarction: A Brief Review.
Genes (Basel). 2025 Jan 6;16(1):59. doi: 10.3390/genes16010059.
3
The Role of High-Resolution Magnetic Resonance Imaging in Cerebrovascular Disease: A Narrative Review.
Brain Sci. 2023 Apr 18;13(4):677. doi: 10.3390/brainsci13040677.
4
Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings.
J Neurosurg. 2013 May;118(5):1030-4. doi: 10.3171/2013.1.JNS12565. Epub 2013 Feb 8.
5
High-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial disease.
Stroke. 2013 Jan;44(1):287-92. doi: 10.1161/STROKEAHA.112.664680. Epub 2012 Nov 29.
本文引用的文献
1
Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management.
Neurosurgery. 2007 Sep;61(3):644-50; discussion 650-1. doi: 10.1227/01.NEU.0000290914.24976.83.
2
Optimal medical therapy with or without PCI for stable coronary disease.
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.
3
US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.
Stroke. 2007 Mar;38(3):881-7. doi: 10.1161/01.STR.0000257963.65728.e8. Epub 2007 Feb 8.
4
MRI of atherosclerosis in clinical trials.
NMR Biomed. 2006 Oct;19(6):636-54. doi: 10.1002/nbm.1065.
5
Clinical features and outcome in North American adults with moyamoya phenomenon.
Stroke. 2006 Jun;37(6):1490-6. doi: 10.1161/01.STR.0000221787.70503.ca. Epub 2006 Apr 27.
6
Quantitative assessment of coronary artery plaque vulnerability by high-resolution magnetic resonance imaging and computational biomechanics: a pilot study ex vivo.
Magn Reson Med. 2005 Dec;54(6):1360-8. doi: 10.1002/mrm.20724.
7
Primary angiitis of the central nervous system at conventional angiography.
Radiology. 2004 Dec;233(3):878-82. doi: 10.1148/radiol.2333031621. Epub 2004 Oct 21.
8
Discrimination of components in atherosclerotic plaques from human carotid endarterectomy specimens by magnetic resonance imaging ex vivo.
Magn Reson Imaging. 2003 Jun;21(5):465-74. doi: 10.1016/s0730-725x(02)00643-4.
9
Clinical features of moyamoya disease in the United States.
Stroke. 1998 Jul;29(7):1347-51. doi: 10.1161/01.str.29.7.1347.
Zotero 插件